Christopher A. Marlett, Director at Cue Biopharma, Inc. (CUE), bought 17,200 shares at $4.53 ($78K) on 2018-12-21, disclosed to the SEC on 2018-12-26.
Open-market purchase of $78k CUE by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| MDBH | BUY | 2025-10-07 | $14K | — | Filing → |
| MDBH | BUY | 2025-08-29 | $11K | — | Filing → |
| MDBH | BUY | 2025-08-27 | $13K | — | Filing → |